Following the appointment of Haseeb Ahmad (pictured above, right) to the role of global head of value and access and commercial development, Chinmay Bhatt (pictured above, left) has taken on the position of managing director UK, Ireland & Nordics for Novartis (NOVN: VX).
Mr Bhatt’s previous role was as the leader of the Novartis Pharma Austria organization from 2017. He was also vice president and board member of the Austrian pharmaceutical trade association, PHARMIG.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze